Moreover, 6MP IC50 tends to be lower in RB1–NUDT15 deleted cells in the majority of cancer types and reached statistical significance in the combined cell lines (Figure 5E–H), indicating that RB1‐deleted tumors may be treatable via collateral lethality. This evidence concerns the gene NUDT15 and cancer.